HOW TO TALK TO YOUR DOCTOR ABOUT CHRONIC CONSTIPATION

Millions of adults have chronic constipation. Even though it’s a personal condition, it’s important to have an honest conversation with your doctor about your symptoms.

This Doctor Discussion Guide can help you capture your symptoms, the effect they have on your daily life, and your current treatments. By sharing these details with your doctor, you are taking an important first step toward finding an appropriate treatment for you.

DOCTOR DISCUSSION GUIDE

Get started (Step 1 of 4)

To create your personalized guide, you’ll be asked about your symptoms, lifestyle, and experience with chronic constipation—everything your doctor needs to know about your condition.

The personal information you provide as part of this tool will be used solely to allow you to generate a discussion guide to share with your healthcare provider. Takeda and other third parties will not collect, store, or use the information you provide in connection with this feature of the AMITIZA website for any other purpose.

Sign up
for support

Get access to emails full of tips and information that can help you manage your chronic constipation.

Register now

Pay $0*
for AMITIZA

Register for an AMITIZA Savings Card to save on prescriptions and refills.

You’ll also receive tips and information about managing your condition.

*Subject to maximum benefit. You must meet Eligibility Requirements.

Start saving

Get to know
real patients

Find out what real patients have to say about their experience with chronic constipation and AMITIZA.

See their stories

Uses & Important Safety Information

AMITIZA is for CIC in adults, OIC in adults with chronic, non-cancer pain, and IBS-C in women ≥ 18 years. Effectiveness in patients taking methadone has not been established.

Important Safety Information

AMITIZA (lubiprostone) is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider (HCP) should evaluate your condition before starting AMITIZA. You should not take AMITIZA if you have severe diarrhea.

Some patients taking AMITIZA may experience nausea or diarrhea. If nausea occurs, take AMITIZA with food and water, if it becomes severe, tell your HCP. If your diarrhea becomes severe, stop taking AMITIZA and tell your HCP.

Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your HCP if you experience these symptoms.

The most common side effects of taking AMITIZA (24 mcg) twice daily are nausea, diarrhea, headache, abdominal pain, abdominal distension, and gas for patients treated for CIC; nausea and diarrhea for patients treated for Opioid-Induced Constipation. The most common side effects of taking AMITIZA (8 mcg) twice daily for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the side effects associated with AMITIZA.

Tell your HCP if you are taking a diphenylheptane opioid (e.g. methadone).

AMITIZA has not been studied in pregnant women. Based on animal studies, AMITIZA may cause fetal harm. AMITIZA should only be used during pregnancy if the potential benefits justify the potential risk to the fetus. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your HCP to evaluate the risks to the fetus. Tell your HCP if you are nursing and monitor infants for diarrhea.

Tell your HCP if you have liver problems.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

AMITIZA (lubiprostone) 24 mcg capsules twice daily is approved to treat Chronic Idiopathic Constipation (CIC) in adults. “Idiopathic” means the cause of the constipation is unknown and not due to an underlying illness or medication. AMITIZA 24 mcg twice daily is also approved to treat constipation caused by opioids (OIC), a type of prescription pain medicine, in adults with chronic, non-cancer pain. The effectiveness of AMITIZA has not been established if you are taking a diphenylheptane opioid (e.g., methadone). AMITIZA 8 mcg capsules twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women 18 years of age and older.

Please click here for complete Prescribing Information.